Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Medicine World Wide » ROSUVASTATIN MOMAJA
Country Product ID Public Price Currency Agent Laboratory Form Dosage Package Size Packaging Route Composition ATC Presentation Pricing Date
Finland 167573 EUR Momaja Tablet, Film-Coated 40mg 28 28kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167568 EUR Momaja Tablet, Film-Coated 20mg 28 28kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167564 EUR Momaja Tablet, Film-Coated 10mg 28 28kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167560 EUR Momaja Tablet, Film-Coated 5mg 28 28kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167574 EUR Momaja Tablet, Film-Coated 40mg 30 30kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167569 EUR Momaja Tablet, Film-Coated 20mg 30 30kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167565 EUR Momaja Tablet, Film-Coated 10mg 30 30kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167561 EUR Momaja Tablet, Film-Coated 5mg 30 30kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167572 EUR Momaja Tablet, Film-Coated 40mg 14 14kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167571 EUR Momaja Tablet, Film-Coated 40mg 7 7kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167575 EUR Momaja Tablet, Film-Coated 40mg 90 90kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167567 EUR Momaja Tablet, Film-Coated 20mg 14 14kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167570 EUR Momaja Tablet, Film-Coated 20mg 90 90kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167563 EUR Momaja Tablet, Film-Coated 10mg 14 14kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167566 EUR Momaja Tablet, Film-Coated 10mg 90 90kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167559 EUR Momaja Tablet, Film-Coated 5mg 14 14kpl Oral Rosuvastatine C10AA07 14/12/2018
Finland 167562 EUR Momaja Tablet, Film-Coated 5mg 90 90kpl Oral Rosuvastatine C10AA07 14/12/2018